RS49840B - Tečne polimerne smeše za kontrolisano oslobađanje bioaktivnih supstanci - Google Patents

Tečne polimerne smeše za kontrolisano oslobađanje bioaktivnih supstanci

Info

Publication number
RS49840B
RS49840B YUP-541/00A YU54100A RS49840B RS 49840 B RS49840 B RS 49840B YU 54100 A YU54100 A YU 54100A RS 49840 B RS49840 B RS 49840B
Authority
RS
Serbia
Prior art keywords
mixture
weight
glycolide
lactide
bioactive substance
Prior art date
Application number
YUP-541/00A
Other languages
English (en)
Serbian (sr)
Inventor
Rey T. CHERN
Joel R. ZINGERMAN
Original Assignee
Merck&Co. Inc.,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck&Co. Inc., filed Critical Merck&Co. Inc.,
Publication of YU54100A publication Critical patent/YU54100A/sh
Publication of RS49840B publication Critical patent/RS49840B/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
YUP-541/00A 1998-03-19 1999-03-18 Tečne polimerne smeše za kontrolisano oslobađanje bioaktivnih supstanci RS49840B (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7957498P 1998-03-19 1998-03-19
GBGB9815801.7A GB9815801D0 (en) 1998-07-21 1998-07-21 Liquid polymeric compositions for controlled released bioactive substances

Publications (2)

Publication Number Publication Date
YU54100A YU54100A (sh) 2002-11-15
RS49840B true RS49840B (sr) 2008-08-07

Family

ID=10835852

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-541/00A RS49840B (sr) 1998-03-19 1999-03-18 Tečne polimerne smeše za kontrolisano oslobađanje bioaktivnih supstanci

Country Status (10)

Country Link
JP (1) JP4829405B2 (de)
AT (1) ATE499069T1 (de)
DE (1) DE69943225D1 (de)
DK (1) DK1484033T3 (de)
GB (1) GB9815801D0 (de)
GE (1) GEP20033012B (de)
PT (1) PT1484033E (de)
RS (1) RS49840B (de)
SI (1) SI1484033T1 (de)
UA (1) UA53788C2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8362086B2 (en) * 2005-08-19 2013-01-29 Merial Limited Long acting injectable formulations
CA2867079A1 (en) * 2012-03-13 2013-09-19 Bayer New Zealand Limited Long acting compositions
RU2690006C2 (ru) * 2013-09-16 2019-05-30 Мерк Шарп И Доум Корп. Композиции антагонистов рецепторов cgrp
KR102101969B1 (ko) * 2017-09-06 2020-04-22 (주)인벤티지랩 목시덱틴을 포함하는 마이크로 입자 및 이의 제조 방법

Also Published As

Publication number Publication date
GB9815801D0 (en) 1998-09-16
DK1484033T3 (da) 2011-06-14
ATE499069T1 (de) 2011-03-15
UA53788C2 (uk) 2003-02-17
DE69943225D1 (de) 2011-04-07
JP4829405B2 (ja) 2011-12-07
PT1484033E (pt) 2011-04-21
SI1484033T1 (sl) 2011-06-30
JP2002506797A (ja) 2002-03-05
GEP20033012B (en) 2003-07-25
YU54100A (sh) 2002-11-15

Similar Documents

Publication Publication Date Title
CA2324265C (en) Liquid polymeric compositions for controlled release of bioactive substances
US6733767B2 (en) Liquid polymeric compositions for controlled release of bioactive substances
RS54100B1 (sr) Supstanca korisna za lečenje poremećaja metabolizma lipida
CN101312710A (zh) 长效可注射杀寄生物制剂
CA2452194A1 (en) Sustained release pharmaceutical compositions comprising a silicone support material
JP2005517653A (ja) X線不透過性徐放性医薬器具
JP4829405B2 (ja) 生体活性物質の制御放出用液体ポリマー組成物
MXPA00009143A (en) Liquid polymeric compositions for controlled release of bioactive substances
HK1031990B (en) Liquid polymeric compositions for controlled release of bioactive substances
HK1036579B (en) Liquid polymeric compositions for controlled release of bioactive substances
AU2002315568B2 (en) Preparation of sustained release pharmaceutical composition
AU2002315568A1 (en) Preparation of sustained release pharmaceutical composition
AU2002366248A1 (en) Radioopaque sustained release pharmaceutical system